Skip to Content
Merck
CN
  • A novel chromatin tether domain controls topoisomerase IIα dynamics and mitotic chromosome formation.

A novel chromatin tether domain controls topoisomerase IIα dynamics and mitotic chromosome formation.

The Journal of cell biology (2013-11-13)
Andrew B Lane, Juan F Giménez-Abián, Duncan J Clarke
ABSTRACT

DNA topoisomerase IIα (Topo IIα) is the target of an important class of anticancer drugs, but tumor cells can become resistant by reducing the association of the enzyme with chromosomes. Here we describe a critical mechanism of chromatin recruitment and exchange that relies on a novel chromatin tether (ChT) domain and mediates interaction with histone H3 and DNA. We show that the ChT domain controls the residence time of Topo IIα on chromatin in mitosis and is necessary for the formation of mitotic chromosomes. Our data suggest that the dynamics of Topo IIα on chromosomes are important for successful mitosis and implicate histone tail posttranslational modifications in regulating Topo IIα.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-polyHistidine antibody produced in mouse, clone HIS-1, ascites fluid
Sigma-Aldrich
Topoisomerase II α human, (Single band on SDS-PAGE), liquid
Sigma-Aldrich
DNA Gyrase from Escherichia coli, aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-phospho-Histone H3 (pSer28) antibody produced in rat, ~0.5 mg/mL, clone HTA28, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-trimethyl-Histone H3 (Lys27) Antibody, Upstate®, from rabbit